Variable expression of presenilin 1 is not a major determinant of risk for late-onset Alzheimer's disease

Journal of Neurology

Volumn 248, Issue 11, 2001, Pages 935-939

  Dermaut, B ^a   Roks, G ^b   Theuns, J ^a   Rademakers, R ^a   Houwing Duistermaat, J J ^b   Serneels, S ^a   Hofman, A ^b   Breteler, M M B ^b   Cruts, M ^a   Van Broeckhoven, C ^a   Van Duijn, C M ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b NONE

Author keywords

Genetic epidemiology; Late onset Alzheimer's disease; Meta analysis; Presenilin 1; Promoter

Indexed keywords

PRESENILIN 1;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; HUMAN; HYPOTHESIS; INTRON; LITERATURE; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RISK ASSESSMENT;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEMBRANE PROTEINS; POLYMORPHISM, GENETIC; PRESENILIN-1; RISK FACTORS;

EID: 0035788767     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150170044     Document Type: Article

References (44)

1. Cruts M, Van Broeckhoven C. Molecular genetics of Alzheimer's disease. Ann Med 1998; 30(6):560-565
2. van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994; 7(1):74-78
3. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997; 278(16):1349-1356
4. Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, Van Broeckhoven C et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 1998; 55(7):964-968
5. Cruts M, van Duijn CM, Backhovens H, Van den Broeck M, Wehnert A, Serneels S et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population based study of presenile Alzheimer disease. Hum Mol Genet 1998; 7(1):43-51
6. van Duijn CM, Cruts M, Theuns J, Van Gassen G, Backhovens H, Van den Broeck M et al. Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample. Eur J Hum Genet 1999; 7(7):801-806
7. Theuns J, Del Favero J, Dermaut B, van Duijn CM, Backhovens H, Van den Broeck M et al. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression. Hum Mol Genet 2000; 9(3):325-331
8. Theuns J, Cruts M, Remacle J, Corsmit E, Huylebroeck D, Van Broeckhoven C. Variable neuron-specific presenilin 1 transcription increases risk for Alzheimer's disease. Neurobiol. Aging 2000; 21: S113
9. Wragg M, Hutton M, Talbot C. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group. Lancet 1996; 347(9000):509-512
10. Isoe K, Urakami K, Ji Y, Adachi Y, Nakashima K. Presenilin-1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia in Japanese population. Acta Neurol Scand 1996; 94(5):326-328
11. Higuchi S, Muramatsu T, Matsushita S, Arai H, Sasaki H. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996; 347(9009):1186
12. Cai X, Stanton J, Fallin D, Hoyne J, Duara R, Gold M et al. No association between the intronic presenilin-1 polymorphism and Alzheimer's disease in clinic and population-based samples. Am J Med Genet 1997; 74(2):202-203
13. Brookes AJ, Howell WM, Woodburn K, Johnstone EC, Carothers A. Presenilin-I, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease. Lancet 1997; 350(9074):336-337
14. Korovaitseva GI, Bukina A, Farrer LA, Rogaev EI. Presenilin polymorphisms in Alzheimer's disease. Lancet 1997; 350(9082):959
15. Hofman A, Grobbee DE, de Jong PT, van-den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991; 7(4):403-422
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3, revised ed. Washington DC: 1987
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34(7):939-944
18. Ott A, Breteler MM, van Harskamp F, Claus JJ, van-der Cammen TJ, Grobbee DE et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ 1995; 310(6985):970-973
19. Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 1998; 147(6):574-580
20. Terwilliger JD, Ott J. Handbook of Human Genetic Linkage. 1994
21. Ezquerra M, Blesa R, Tolosa E, Ballesta F, Oliva R. Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population. Neurosci Lett 1998; 240(2):107-109
22. Hu CJ, Sung SM, Liu HC, Chang JG. Association of apolipoprotein E genotype and intronic polymorphism of the presenilin-1 gene with Alzheimer's disease in elderly Taiwan Chinese. J Neurol Sci 1998; 157(2):158-161
23. Kehoe P, Williams J, Holmans P, Liddell M, Lovestone S, Holmes C et al. Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease. Neuroreport 1996; 7(13):2155-2158
24. Kowalska A, Wender M, Lannfelt L. Lack of association between an intronic polymorphism in the presenilin-1 gene and sporadic late-onset Alzheimer disease in Polish patients. Dement Geriatr Cogn Disord 1998; 9(3):137-139
25. Lendon CL, Myers A, Cumming A, Goate AM, St. Clair D. A polymorphism in the presenilin 1 gene does not modify risk for Alzheimer's disease in a cohort with sporadic early onset. Neurosci Lett 1997; 228(3):212-214
26. Liao A, Gomez-Isla T, Clatworthy A, Hyman BT. Lack of association of presenilin-1 intron-8 polymorphism with neuropathological features of Alzheimer's disease. Brain Res 1999; 816(2):295-298
27. Nishiwaki Y, Kamino K,Yoshiiwa A, Sato N, Tateishi K, Takeda M et al. T/G polymorphism at intron 9 of presenilin 1 gene is associated with, but not responsible for sporadic late-onset Alzheimer's disease in Japanese population. Neurosci Lett 1997; 227(2):123-126
28. Perez-Tur J, Wavrant-De Vrieze F, Lambert JC, Chartier Harlin M. Presenilin-1 polymorphism and Alzheimer's disease. The Alzheimer's Study Group. Lancet 1996; 347(9014):1560-1561
29. Scacchi R, Gambina G, Ruggeri M, Martini MC, Ferrari G, Silvestri M et al. Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease. Neurosci Lett 1999; 259(1):33-36
30. Scott WK,Yamaoka LH, Locke PA, Rosi BL, Gaskell PC, Saunders AM et al. No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease. Genet Epidemiol 1997; 14(3):307-315
31. Singleton AB, Lamb H, Leake A, Mc-Keith IG, Perry RH, Morris CM. No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer's disease. Neurosci Lett 1997; 234(1):19-22
32. Sodeyama N, Itoh Y, Suematsu N, Matsushita M, Otomo E, Mizusawa H et al. Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease. J Neurol Neuro-surg Psychiatry 1998; 64(4):548-551
33. Sorbi S, Nacmias B, Tedde A, Forleo P, Piacentini S, Latorraca S et al. Presenilin-1 gene intronic polymorphism in sporadic and familial Alzheimer's disease. Neurosci Lett 1997; 222(2):132-134
34. Tysoe C, Whittaker J, Cairns NJ, Atkinson PF, Harrington CR, Xuereb J et al. Presenilin-1 intron 8 polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease. Neurosci Lett 1997; 222(1):68-69
35. Wang X, Dekosky ST, Wisniewski S, Aston, Kamboh MI. Genetic association of two chromosome 14 genes (presenilin 1 and alpha 1-antichymotrypsin) with Alzheimer's disease. Ann Neurol 1998; 44(3):387-390
36. Wragg MA, Talbot CJ, Morris JC, Lendon CL, Goate AM. No association found between Alzheimer's disease and a mitochondrial tRNA glutamine gene variant. Neurosci Lett 1995; 201(2):107-110
37. Wu X, Jiang S, Lin S, Tang G, Feng G, Qian Y et al. No association between the intronic presenilin 1 polymorphism and Alzheimer's disease in the Chinese population. Am J Med Genet 1999; 88(1):1-3
38. Yasuda M, Hirono N, Maeda K, Imamura T, Mori E, Tanaka C. Case-control study of presenilin-1 intronic polymorphism in sporadic early and late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999; 66(6):722-726
39. Taddei K,Yang D, Fisher C, Clarnette R, Hallmayer J, Barnetson R et al. No association of presenilin-1 intronic polymorphism and Alzheimer's disease in Australia. Neurosci Lett 1998; 246(3):178-180
40. Scott WK, Roses AD, Haines JL, Pericak-Vance MA. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996; 347(9014):1560
41. Matsushita S, Arai H, Muramatsu T, Makimoto K, Nakagawa T, Sasaki H et al. Presenilin-1 polymorphism in Alzheimer's disease and vascular dementia. Exp Neurol 1997; 146(2):567-569
42. Normand SL. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 1999; 18(3):321-359
43. Refolo LM, Eckman C, Prada CM, Yager D, Sambamurti K, Mehta N et al. Antisense-induced reduction of presenilin 1 expression selectively increases the production of amyloid beta42 in transfected cells. J Neurochem 1999; 73(6):2383-2388
44. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998; 391(6665):387-390